Clinical Trial Update: Therapy for Locally Advanced Breast Cancer Using Doxil, Paclitaxel, and Cyclophosphamide With Avastin [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the combination of liposomal doxorubicin (Doxil), paclitaxel, cyclophosphamide with bevacizumab (Avastin) in invasive breast cancer; st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Avastin (bevacizumab)
• Cytoxan (cyclophosphamide)
• Doxil (liposomal doxorubicin)
• Taxol (paclitaxel)

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Invasive Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2016-06-15